GSK lifts long-term sales targets on new drug pipeline
As a result, the company said it is targeting total sales of more than £40 billion by 2031, hiking its previous target of ...
Investing8m
European stocks slip lower; earnings, services PMI data in focus
TotalEnergies (EPA: TTEF) raised its dividend Wednesday, as the French energy giant attempted to appease investors after a ...
GSK FY24 Core Operating Profit Rises, Turnover Up 7% At CER; Increases 2031 Sales Outlook
GSK (GSK.L, GSK) reported fiscal 2024 profit before tax of 3.5 billion pounds, down 43% at AER, or down 34% at CER from prior year.
Buy25m
LONDON BRIEFING: GSK hails pipeline as ups 2031 sales target
In early UK corporate news, GSK announced a buyback and upped its 2031 sales target. Here is what you need to know at the London market open: FTSE 100: called down 0.3% at 8,542.57 Hang Seng: down 1.0 ...
GSK Expects Further Profit Growth After Beating Market Views
The pharmaceutical giant targets an increase in core operating profit of between 6% and 8% in 2025, after cancer treatments ...
Insider40m
GSK lifts sales guidance after “excellent” performance in 2024
Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline.
GSK beats Q4 earnings estimates, lifts 2031 sales target
GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...
GSK launches £2bn buyback plan, lifts long-term guidance
GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its ...